These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22828012)

  • 1. Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats.
    Thompson KL; Zhang J; Stewart S; Rosenzweig BA; Shea K; Mans D; Colatsky T
    Toxicol Lett; 2012 Sep; 213(2):285-91. PubMed ID: 22828012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the diagnostic accuracy of di-22:6-bis(monoacylglycerol)phosphate and other urinary phospholipids for drug-induced phospholipidosis or tissue injury in the rat.
    Thompson KL; Haskins K; Rosenzweig BA; Stewart S; Zhang J; Peters D; Knapton A; Rouse R; Mans D; Colatsky T
    Int J Toxicol; 2012; 31(1):14-24. PubMed ID: 22267869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
    Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment.
    Liu N; Tengstrand EA; Chourb L; Hsieh FY
    Toxicol Appl Pharmacol; 2014 Sep; 279(3):467-476. PubMed ID: 24967688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualified method for the estimation of di-18:1 bis(monoacylglycero)phosphate in urine, a noninvasive biomarker to monitor drug-induced phospholipidosis.
    Murali BV; Kurawattimath V; Bhutani P; Onorato J; Naikodi SB; Kole P; Rajanna PK
    Bioanalysis; 2020 Aug; 12(15):1049-1059. PubMed ID: 32735140
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N; Giantin M; Crivellente F; Ferraresso S; Faustinelli I; Dacasto M; Cristofori P
    J Appl Toxicol; 2015 Jan; 35(1):90-103. PubMed ID: 25580480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity.
    Yang X; Greenhaw J; Shi Q; Su Z; Qian F; Davis K; Mendrick DL; Salminen WF
    Toxicol Sci; 2012 Feb; 125(2):335-44. PubMed ID: 22112502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast-enhanced Magnetic Resonance Imaging.
    Lenhard SC; Lev M; Webster LO; Peterson RA; Goulbourne CN; Miller RT; Jucker BM
    Toxicol Pathol; 2016 Jan; 44(1):51-60. PubMed ID: 26516164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.
    Tengstrand E; Zhang H; Liu N; Dunn K; Hsieh F
    Toxicol Appl Pharmacol; 2019 Mar; 366():54-63. PubMed ID: 30653977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of a potential biomarker of phospholipidosis from amiodarone-treated rats.
    Mortuza GB; Neville WA; Delaney J; Waterfield CJ; Camilleri P
    Biochim Biophys Acta; 2003 Mar; 1631(2):136-46. PubMed ID: 12633679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum neopterin levels in acetaminophen-induced liver injury.
    Demirbas S; Cakir E; Akgul EO; Seyrek M; Cayci T; Kurt YG; Uysal B; Aydin I; Kurt B; Yaman H; Erbil MK
    Environ Toxicol Pharmacol; 2011 Jan; 31(1):165-70. PubMed ID: 21787682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J; Neville WA; Swain A; Miles A; Leonard MS; Waterfield CJ
    Biomarkers; 2004; 9(3):271-90. PubMed ID: 15764292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
    Hasegawa M; Takenaka S; Kuwamura M; Yamate J; Tsuyama S
    Exp Toxicol Pathol; 2007 Oct; 59(2):115-20. PubMed ID: 17719757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
    Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD
    Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of lysosomal phospholipase A2 in the catabolism of bis(monoacylglycerol)phosphate and association with phospholipidosis.
    Abe A; Hinkovska-Galcheva V; Bouchev P; Bouley R; Shayman JA
    J Lipid Res; 2024 Jul; 65(7):100574. PubMed ID: 38857781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis(monoacylglycero)phosphate, a new lipid signature of endosome-derived extracellular vesicles.
    Rabia M; Leuzy V; Soulage C; Durand A; Fourmaux B; Errazuriz-Cerda E; Köffel R; Draeger A; Colosetti P; Jalabert A; Di Filippo M; Villard-Garon A; Bergerot C; Luquain-Costaz C; Moulin P; Rome S; Delton I; Hullin-Matsuda F
    Biochimie; 2020 Nov; 178():26-38. PubMed ID: 32659447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin 3 as a potential biomarker of acetaminophen-induced liver injury.
    Yaman H; Cakir E; Akgul EO; Aydin I; Onguru O; Cayci T; Kurt YG; Agilli M; Aydin FN; Gulec M; Altinel O; Isbilir S; Ersoz N; Yasar M; Turker T; Bilgi C; Erbil KM
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):147-51. PubMed ID: 21880472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.